Lila Bio
Lila Bio develops therapeutic proteins using AI-powered protein design and experimental discovery platforms. Its targeted radiotherapy platform focuses on solid tumors, while its long-acting injectable platform targets non-oncology diseases; the company aims to develop medicines that improve care for people with cancer and other debilitating diseases.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2023
- Employees
- 10
- Members see funding amounts. .
- Founders
- Jake Kraft, PhD, Anindya Roy, PhD, Hua Bai, PhD, Sheila Gujrathi, MD
Is this your organization? Claim it
Founders
-
Anindya Roy Executive Officer, Director, CSO & Co-Founder
-
Jake Kraft CEO & Co-Founder
-
Hua Bai Director of Protein Design & Co-Founder
Executives
-
Kimberly Ma Executive, Chief Development Officer